World Diabetes & Endocrinology Conference(WDEC 2023) Date: October 09-11 , 2023 Venue: Barcelona, Spain..
WDEC 2023

World Diabetes & Endocrinology Conference

×
  • Home
  • About Conference
  • Program
    • Scientific Program
    • Organizing Committee
    • Faculty
  • Abstracts
  • Registration
  • Venue
  • General Info
    • Important Dates
    • Guidelines
    • Best Oral and Poster Awards
    • Terms and Conditions
    • FAQ
  • Contact

Dr Bob Ryder

Chief investigator, Association of British Clinical Diabetologists

United Kingdom

Chief investigator ABCD REVISE-Diabesity and End-OSA Studies with Endobarrier

Clinical lead, ABCD worldwide EndoBarrier registry

Clinical lead, ABCD audits of new diabetes therapies and devices

Author: An Aid to the MRCP Short Cases

An Aid to the MRCP PACES

Consultant Diabetologist

City Hospital

UK

 

Co-opted Website Co-ordinator & Clinical Lead, Nationwide Audits of New Diabetes Therapies

Bob Ryder trained in South Wales and Sheffield. He has worked as a Consultant Physician/Diabetologist/Endocrinologist, City Hospital, Birmingham since 1991. Over the years special interests have included diabetic retinopathy screening; diabetic hypoglycaemia unawareness; diabetic autonomic neuropathy; diabetic impotence; clinical use of IT; treating to target; relative risks and benefits of pioglitazone He leads the ABCD nationwide audits of new therapies and devices – current audits include SGLT2i, FreeStyle Libre, semaglutide, COVID 19 and diabetes, testosterone, closed-loop systems, oral semaglutide and Omnipod. He is chief investigator of two ABCD Endobarrier studies. Beyond diabetes he is best known as principal author of best-selling "An Aid to the MRCP Short Cases", the 4th-edition of which is the three volume “An Aid to the MRCP PACES”.

WDEC 2023

Quick Links

  • Important Dates
  • Abstract Submission
  • Scientific Program
  • Contact
  • Registration

Follow & Share